RG
TMDX icon

Renaissance Group’s Transmedics TMDX Stock Holding History

Renaissance Group’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.18M Buy
108,157
+14,614
+16% +$1.24M 0.29% 103
2026
Q1 		$9.3M Buy
93,543
+16,314
+21% +$2.13M 0.39% 77
2025
Q4 		$9.39M Buy
77,229
+1,151
+2% +$144K 0.38% 65
2025
Q3 		$8.54M Buy
+76,078
New +$8.91M 0.32% 78
2025
Q1 		– Sell
-30,596
Closed -$1.91M – 259
2024
Q4 		$1.91M Buy
+30,596
New +$2.85M 0.08% 155

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Renaissance Group's TMDX Position: Q2 2026 in Review

Renaissance Group increased its Transmedics (TMDX) stake by 16% in Q2 2026, buying an estimated $1.24M and bringing the position to 108,157 shares worth $7.18M. The position accounts for 0.29% of the portfolio, ranked #103.

Renaissance Group first reported a position in TMDX in Q4 2024 and has held it in 5 quarters since. The position peaked at $9.39M in Q4 2025. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Renaissance Group held 108,157 shares of Transmedics worth $7.18M as of Q2 2026.
  • Renaissance Group bought 14,614 Transmedics shares in Q2 2026, an estimated $1.24M.
  • Transmedics made up 0.29% of Renaissance Group's portfolio in Q2 2026, its #103 holding.
  • Renaissance Group first reported a position in Transmedics in Q4 2024 and has held it in 5 quarters since.
  • Renaissance Group's Transmedics position peaked at $9.39M in Q4 2025.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Renaissance Group's 13F filing for Q2 2026, filed 13 Aug 2026.